Levels of lipoprotein Lp(a) decline with neomycin and niacin treatment
- 30 November 1985
- journal article
- Published by Elsevier BV in Atherosclerosis
- Vol. 57 (2-3), 293-301
- https://doi.org/10.1016/0021-9150(85)90041-3
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Normalization of plasma lipoprotein concentrations in patients with type II hyperlipoproteinemia by combined use of neomycin and niacin.Circulation, 1984
- Reduction of lecithin-cholesterol acyltransferase, apolipoprotein D and the Lp(a) lipoprotein with the anabolic steroid stanozololBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1984
- The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: results of NHLBI Type II Coronary Intervention Study.Circulation, 1984
- Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study.Circulation, 1984
- The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol loweringJAMA, 1984
- The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart diseaseJAMA, 1984
- Quantitative genetic studies of the human plasma Lp(a) lipoproteinBiochemical Genetics, 1974
- Lp(a) LIPOPROTEIN AND PRE‐β1‐LIPOPROTEIN IN YOUNG ADULTSActa Medica Scandinavica, 1974
- Protein and carbohydrate composition of Lp(a) lipoprotein from human plasmaBiochemistry, 1972
- Human serum lipoproteins. Evidence for three classes of lipoproteins in SfO-2Biochemistry, 1972